VahatiCor specializes in developing innovative medical solutions for coronary microvascular dysfunction. Their flagship product, the A-FLUX Reducer System, aims to alleviate chronic symptoms such as chest pain and shortness of breath in patients. It is important to note that this system is currently an experimental treatment and is not approved for ischemic heart disease in the U.S.